港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

医美概念股

687.595

-29.646-4.13%

涨家数：3

跌家数：7

平家数：3

市盈率：- -

高：696.344

开：678.885

低：675.692

收：717.241

数据加载中...

总览新闻资讯

每日卖空追踪 | 康哲药业 04月23日卖空量成交279.8万股，卖空比例为11.89%

康哲药业分拆“德镁医药”，来自海南海口，拟以介绍方式赴香港上市，递交上市申请

港股异动 | 时代天使(06699)涨超4% 公司股东李华敏收购上海恺皓40%股权

康哲药业盘中涨超4% 建议分拆德镁医药股份于联交所主板独立上市

港股异动 | 康哲药业(00867)涨超4% 建议分拆德镁医药股份于联交所主板独立上市

康哲药业盘中异动早盘股价大涨5.04%报8.550港元

【湾区早参】香港最新失业率维持3.2%；澳门推出《2025年中小企业银行贷款利息补贴计划》

康哲药业：分拆德镁医药上市潜力有望迎来释放

康哲药业(00867)建议分拆德镁医药股份于联交所主板独立上市

山河药辅增收不增利！董事长连年涨薪，大股东复星医药频繁减持套现

读创客户端

非执行董事张皎娥减持三生制药(01530)2.6万股每股作价12.94港元

智通财经网

复星医药收盘上涨2.09%，滚动市盈率23.53倍，总市值651.80亿元

三生制药04月22日主力净流入764万元散户资金抛售

四环医药04月22日主力净流入924万元散户资金抛售

康哲药业04月22日获主力加仓829万元

时代天使04月22日获主力加仓17万元

时代天使股东李华敏收购上海恺皓40%股权关联关系确立

复星医药，增持复宏汉霖至63.43%

国信证券：关注出海加速的创新药以及政策支持的服务板块

复宏汉霖盘中涨超9% 复星医药拟5.17亿港元增持复宏汉霖3.87%股权

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK1593/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"医美概念股","latestPrice":687.59454,"timestamp":1745824740146,"preClose":717.24054,"halted":0,"volume":146894458,"delay":0,"changeRate":-0.041333,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-29.645996,"latestTime":"04-28 15:19:03","open":678.8851,"high":696.34436,"low":675.6922,"amount":1219503845,"amplitude":0.028794,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1745827800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1745803800000,1745812800000],[1745816400000,1745827200000]],"pbRate":1.255448,"peRate":19.315719,"turnoverRate":0.007346,"increases":3,"decrements":7,"flats":3,"marketCap":118397825768,"floatMarketCap":82415257704},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":696.34436,"amplitude":0.028794,"preClose":717.24054,"low":675.6922,"pbRate":"1.255448","latestPrice":687.59454,"volume":146894458,"delay":0,"open":678.8851,"prevYearClose":571.87146,"prevWeekClose":717.241,"prevMonthClose":677.607,"prevQuarterClose":677.607,"fiveDayClose":661.02,"twentyDayClose":662.617,"sixtyDayClose":538.937,"secType":"PLATE","market":"HK","turnoverRate":0.007346,"peRate":19.315719,"marketCap":118397825768,"floatMarketCap":82415257704,"timestamp":1745824740146,"nameCN":"医美概念股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":3,"down":7,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529578580","title":"每日卖空追踪 | 康哲药业 04月23日卖空量成交279.8万股，卖空比例为11.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529578580","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529578580?lang=zh_cn&edition=fundamental","pubTime":"2025-04-23 17:09","pubTimestamp":1745399368,"startTime":"0","endTime":"0","summary":"康哲药业北京时间04月23日，涨4.79%，卖空量成交279.8万股，较上一交易日增加148.05%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423172043a463afce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423172043a463afce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999004220.SGD","SG9999015945.SGD","IE00BYV24P56.USD","LU2488822045.USD","SG9999015952.SGD","SG9999015986.USD","BK1593","BK1191","00867","SG9999015978.USD","IE00BMCWC346.EUR"],"gpt_icon":0},{"id":"2529545328","title":"康哲药业分拆“德镁医药”，来自海南海口，拟以介绍方式赴香港上市，递交上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2529545328","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529545328?lang=zh_cn&edition=fundamental","pubTime":"2025-04-23 13:04","pubTimestamp":1745384640,"startTime":"0","endTime":"0","summary":"　　2025年4月22日，康哲药业分拆德镁医药有限公司Dermavon Holdings Limited在港交所递交上市申请，拟以介绍方式在香港主板上市。　　德镁医药，成立于2020年，总部位于海南海口，作为一家中国领先、专业聚焦皮肤健康的创新型医药企业，围绕皮肤处方药及皮肤学级护肤品的研、产、销一体化运营，致力于提供从预防、治疗到长期护理的皮肤健康综合解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-04-23/doc-ineucptw3299749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["00867","BK1161","SG9999015986.USD","LU2488822045.USD","SG9999015952.SGD","BK1191","SG9999015945.SGD","IE00BMCWC346.EUR","SG9999015978.USD","159938","BK1574","BK1515","SG9999004220.SGD","09939","IE00BYV24P56.USD","BK1593"],"gpt_icon":0},{"id":"2529153095","title":"港股异动 | 时代天使(06699)涨超4% 公司股东李华敏收购上海恺皓40%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2529153095","media":"智通财经","labels":["shareholding","merge","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529153095?lang=zh_cn&edition=fundamental","pubTime":"2025-04-23 10:41","pubTimestamp":1745376090,"startTime":"0","endTime":"0","summary":"消息面上，4月22日，时代天使发布公告，上海恺皓已成为公司的关联人士，原因是公司主要股东李华敏已收购上海恺皓总股权的40%。因此，上海恺皓与公司之间的加工承包协议项下的持续交易已成为公司的持续关联交易。加工承包协议于2024年10月28日签订，主要条款包括上海恺皓根据无锡时代天使的购买订单提供原材料加工服务，协议有效期至2025年12月31日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282922.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","06699","BK1100","BK1583","BK1593"],"gpt_icon":0},{"id":"2529851655","title":"康哲药业盘中涨超4% 建议分拆德镁医药股份于联交所主板独立上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2529851655","media":"新浪网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529851655?lang=zh_cn&edition=fundamental","pubTime":"2025-04-23 10:32","pubTimestamp":1745375552,"startTime":"0","endTime":"0","summary":"康哲药业盘中涨超4%，截至发稿，股价上涨2.95%，现报8.38港元，成交额7606.41万港元。4月22日晚间，康哲药业发布公告，公司建议将公司附属公司德镁医药股份分拆并于联交所主板独立上市。建议分拆（倘进行）预计将透过由公司以实物方式向股东分派其持有的所有德镁医药股份的方式实施，分派比例将按截至董事会为确定股东权利而厘定的记录日期当日彼等各自于公司的持股比例计算。联交所已确认公司可进行建议分拆事宜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042311020294def9d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042311020294def9d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","SG9999004220.SGD","SG9999015945.SGD","IE00BYV24P56.USD","LU2488822045.USD","SG9999015952.SGD","IE00BMCWC346.EUR","SG9999015986.USD","BK1593","BK1191","BK1515","BK1574","BK1161","SG9999015978.USD","00867"],"gpt_icon":0},{"id":"2529920385","title":"港股异动 | 康哲药业(00867)涨超4% 建议分拆德镁医药股份于联交所主板独立上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2529920385","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529920385?lang=zh_cn&edition=fundamental","pubTime":"2025-04-23 09:50","pubTimestamp":1745373044,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，康哲药业涨超4%，截至发稿，涨4.67%，报8.52港元，成交额3570.65万港元。消息面上，4月22日晚间，康哲药业发布公告，公司建议将公司附属公司德镁医药股份分拆并于联交所主板独立上市。建议分拆(倘进行)预计将透过由公司以实物方式向股东分派其持有的所有德镁医药股份的方式实施，分派比例将按截至董事会为确定股东权利而厘定的记录日期当日彼等各自于公司的持股比例计算。联交所已确认公司可进行建议分拆事宜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282894.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BYV24P56.USD","BK1593","IE00BMCWC346.EUR","SG9999015945.SGD","SG9999015952.SGD","BK1191","BK1574","SG9999004220.SGD","SG9999015978.USD","LU2488822045.USD","BK1161","09939","159938","SG9999015986.USD","BK1515","00867"],"gpt_icon":0},{"id":"2529592679","title":"康哲药业盘中异动 早盘股价大涨5.04%报8.550港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529592679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529592679?lang=zh_cn&edition=fundamental","pubTime":"2025-04-23 09:37","pubTimestamp":1745372279,"startTime":"0","endTime":"0","summary":"2025年04月23日早盘09时37分，康哲药业股票出现波动，股价急速上涨5.04%。截至发稿，该股报8.550港元/股，成交量219.3万股，换手率0.09%，振幅4.05%。资金方面，该股资金流入1027.73万港元，流出598.138万港元。最近的财报数据显示，该股实现营业收入80.66亿港元，净利润17.49亿港元，每股收益0.72港元，毛利58.55亿港元，市盈率11.92倍。康哲药业股票所在的药品行业中，整体涨幅为0.25%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423093759974163a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423093759974163a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999015952.SGD","IE00BMCWC346.EUR","00867","BK1191","SG9999015945.SGD","SG9999004220.SGD","LU2488822045.USD","SG9999015986.USD","SG9999015978.USD","BK1593","IE00BYV24P56.USD"],"gpt_icon":0},{"id":"2529932805","title":"【湾区早参】香港最新失业率维持3.2%；澳门推出《2025年中小企业银行贷款利息补贴计划》","url":"https://stock-news.laohu8.com/highlight/detail?id=2529932805","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529932805?lang=zh_cn&edition=fundamental","pubTime":"2025-04-23 08:20","pubTimestamp":1745367606,"startTime":"0","endTime":"0","summary":"就业不足率在该两段期间亦保持不变，维持于1.1%的水平。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1957517","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015952.SGD","IE00BMCWC346.EUR","LU2488822045.USD","LU1634259391.SGD","BK1515","SG9999015986.USD","BK1593","LU1481107354.HKD","LU1497734951.SGD","80883","LU1497733557.USD","01057","LU1634259557.SGD","LU2543165471.USD","BK1224","LU1226288253.USD","LU0348766576.USD","01672","LU0531971595.HKD","BK1161","02218","SG9999002950.SGD","BK1144","BK1574","BK1237","00941","BK1505","LU0823426308.USD","09992","LU1951186391.HKD","IE00BYV24P56.USD","BK1536","LU0164865239.USD","LU0164880469.USD","SG9999004220.SGD","BK1152","BK1589","LU1226287529.USD","SG9999015978.USD","LU1522347837.USD","00867","LU0871576103.HKD","LU1226287875.USD","LU0348767384.USD","LU1226287792.SGD","BK1521","LU1226288170.HKD","LU0039217434.USD","LU0823426480.USD","02068"],"gpt_icon":1},{"id":"2529996305","title":"康哲药业：分拆德镁医药上市 潜力有望迎来释放","url":"https://stock-news.laohu8.com/highlight/detail?id=2529996305","media":"中金公司","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529996305?lang=zh_cn&edition=fundamental","pubTime":"2025-04-23 00:00","pubTimestamp":1745337600,"startTime":"0","endTime":"0","summary":"公司近况4 月22 日晚，公司公告建议分拆子公司德镁医药于港交所主板独立上市，分拆建议仍需取决于相关部门批准、公司董事会以及德镁医药董事会批准。根据公告，建议分拆（若进行）采用实物方式向股东分派其持有所有德镁医药股份方式实施，股东享有的德镁医药股权不会被稀释。目前德镁医药90.8%股权由康哲药业持有，9.2%股权由两个员工激励平台持有。分拆完成上市后，康哲药业与德镁医药将各自拥有独立上市地位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423090620a6c475ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423090620a6c475ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","LU2488822045.USD","SG9999015978.USD","SG9999015986.USD","SG9999015952.SGD","BK1191","00867","BK1574","SG9999004220.SGD","09939","IE00BMCWC346.EUR","BK1161","IE00BYV24P56.USD","BK1515","SG9999015945.SGD"],"gpt_icon":0},{"id":"2529585619","title":"康哲药业(00867)建议分拆德镁医药股份于联交所主板独立上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2529585619","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529585619?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 21:36","pubTimestamp":1745329000,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康哲药业 公布，公司建议将公司附属公司德镁医药股份分拆并于联交所主板独立上市。建议分拆(倘进行)预计将透过由公司以实物方式向股东分派其持有的所有德镁医药股份的方式实施，分派比例将按截至董事会为确定股东权利而厘定的记录日期当日彼等各自于公司的持股比例计算。联交所已确认公司可进行建议分拆事宜。据悉，德镁医药是一家在开曼群岛注册成立的获豁免有限公司，为公司的附属公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282603.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09939","SG9999004220.SGD","SG9999015945.SGD","IE00BYV24P56.USD","LU2488822045.USD","SG9999015952.SGD","IE00BMCWC346.EUR","SG9999015986.USD","BK1593","159938","BK1191","BK1515","BK1574","BK1161","SG9999015978.USD","00867"],"gpt_icon":0},{"id":"2529637242","title":"山河药辅增收不增利！董事长连年涨薪，大股东复星医药频繁减持套现","url":"https://stock-news.laohu8.com/highlight/detail?id=2529637242","media":"读创客户端","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529637242?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 19:08","pubTimestamp":1745320115,"startTime":"0","endTime":"0","summary":"进入2025年，山河药辅同样面临增收不增利的困境。股东方面，截至一季度末，尹正龙持有山河药辅26.90%股权，为其控股股东；上海复星医药产业发展有限公司持有山河药辅10.16%股权，为其第二大股东。2月23日晚间，山河药辅公告称，股东复星医药因经营需要拟减持本公司股份不超过697.8万股，即不超过公司总股本的3%。以此计算，复星医药套现约2770.27万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042219152794de0564&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042219152794de0564&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02196","BK1593","BK1191","BK1515"],"gpt_icon":0},{"id":"2529303508","title":"非执行董事张皎娥减持三生制药(01530)2.6万股 每股作价12.94港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529303508","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529303508?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 18:56","pubTimestamp":1745319360,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示，4月15日，非执行董事张皎娥减持三生制药(01530)2.6万股，每股作价12.94港元，总金额为33.644万港元。减持后最新持股数目约为1249.26万股，最新持股比例为0.52%。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-04-22/doc-inetzzsn7529454.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1593","BK1583","BK1161","01530"],"gpt_icon":0},{"id":"2529277653","title":"复星医药收盘上涨2.09%，滚动市盈率23.53倍，总市值651.80亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529277653","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529277653?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 17:56","pubTimestamp":1745315803,"startTime":"0","endTime":"0","summary":"4月22日，复星医药今日收盘24.4元，上涨2.09%，滚动市盈率PE达到23.53倍，创13天以来新低，总市值651.80亿元。从行业市盈率排名来看，公司所处的化学制药行业市盈率平均47.61倍，行业中值28.57倍，复星医药排名第76位。截至2024年年报，共有39家机构持仓复星医药，其中基金39家，合计持股数6857.75万股，持股市值17.03亿元。上海复星医药(集团)股份有限公司的主营业务是制药、医疗器械、医学诊断、医疗健康服务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/22175649755974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1515","BK0060","600196","02196","BK0096","BK0196","BK0175","BK0028","BK1191","BK0183","BK0012","BK0187","BK0188","BK1593","BK0239"],"gpt_icon":0},{"id":"2529132158","title":"三生制药04月22日主力净流入764万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2529132158","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529132158?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 16:17","pubTimestamp":1745309832,"startTime":"0","endTime":"0","summary":"04月22日, 三生制药股价涨4.68%，报收12.52元，成交金额5.35亿元，换手率1.79%，振幅7.36%，量比0.96。三生制药今日主力资金净流入764万元，上一交易日主力净流出291万元。该股近5个交易日下跌0.97%，主力资金累计净流入6459万元；近20日主力资金累计净流入3.28亿元，其中净流入天数为16日。该股主力净额占比0.03%，港股市场排名222/2647。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422171639a6c38d1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422171639a6c38d1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","01530","BK1593","BK1161"],"gpt_icon":0},{"id":"2529297723","title":"四环医药04月22日主力净流入924万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2529297723","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529297723?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 16:16","pubTimestamp":1745309773,"startTime":"0","endTime":"0","summary":"04月22日, 四环医药股价涨4.76%，报收0.66元，成交金额3038万元，换手率0.51%，振幅4.76%，量比1.95。四环医药今日主力资金净流入924万元，上一交易日主力净流出92万元。该股近5个交易日上涨1.59%，主力资金累计净流入960万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入2066万元，其中净流入天数为11日。该股主力净额占比0.16%，港股市场排名48/2647。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422171112a6c38b9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422171112a6c38b9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1600","BK1515","BK1191","00460","BK1593"],"gpt_icon":0},{"id":"2529831321","title":"康哲药业04月22日获主力加仓829万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529831321","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529831321?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 16:16","pubTimestamp":1745309765,"startTime":"0","endTime":"0","summary":"04月22日, 康哲药业股价涨10.75%，报收8.14元，成交金额1.14亿元，换手率0.58%，振幅12.24%，量比1.74。康哲药业今日主力资金净流入829万元，上一交易日主力净流入153万元。该股近5个交易日上涨9.82%，主力资金累计净流入1460万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入5460万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422171027a4623a7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422171027a4623a7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","IE00BYV24P56.USD","SG9999015952.SGD","BK1191","SG9999015945.SGD","SG9999015978.USD","SG9999004220.SGD","BK1593","SG9999015986.USD","IE00BMCWC346.EUR","00867"],"gpt_icon":0},{"id":"2529256943","title":"时代天使04月22日获主力加仓17万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529256943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529256943?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 16:15","pubTimestamp":1745309722,"startTime":"0","endTime":"0","summary":"04月22日, 时代天使股价涨4.59%，报收48.95元，成交金额4137万元，换手率0.50%，振幅5.13%，量比1.34。时代天使今日主力资金净流入17万元，上一交易日主力净流入52万元。该股近5个交易日上涨1.88%，主力资金累计净流出682万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出1935万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422170609a6c389fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422170609a6c389fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","BK1593","06699","BK1583","BK1587"],"gpt_icon":0},{"id":"2529310883","title":"时代天使股东李华敏收购上海恺皓40%股权 关联关系确立","url":"https://stock-news.laohu8.com/highlight/detail?id=2529310883","media":"财中社","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529310883?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 14:52","pubTimestamp":1745304755,"startTime":"0","endTime":"0","summary":"4月22日，时代天使（06699）发布公告，上海恺皓已成为公司的关联人士，原因是公司主要股东李华敏已收购上海恺皓总股权的40%。因此，上海恺皓与公司之间的加工承包协议项下的持续交易已成为公司的持续关联交易。根据上市规则第14A.60条，公司需遵守年度审阅及披露规定。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504223384285745.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06699","BK1100","BK1587","BK1593","BK1583"],"gpt_icon":0},{"id":"2529124313","title":"复星医药，增持复宏汉霖至63.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529124313","media":"市场资讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529124313?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 13:03","pubTimestamp":1745298180,"startTime":"0","endTime":"0","summary":"　　复星医药发公告指，上周四斥资3.68亿港元增持复宏汉霖约1494.07万股非上市股份，平均每股作价24.6港元，卖方为生物科技投资公司HenLink。　　复星医药又在4月15日与舟山果运签订股份转让协议，向对方收购138.12万股复宏汉霖非上市股份，每股代价为24.6港元，涉3397.75万港元。　　上述数项交易完成后，复星医药持有复宏汉霖股权比例会由59.56%增加至63.43%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-04-22/doc-inetzkuw4200955.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","BK0060","600196","02196","BK0096","BK0196","BK0175","BK0028","BK1161","BK1191","BK0183","BK0012","02696","BK0187","BK0188","BK1593","BK0239"],"gpt_icon":0},{"id":"2529394377","title":"国信证券：关注出海加速的创新药以及政策支持的服务板块","url":"https://stock-news.laohu8.com/highlight/detail?id=2529394377","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529394377?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 11:00","pubTimestamp":1745290808,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，国信证券发布研报称，从2025年初以来，国产创新药企业已经完成了几十笔对外授权的交易，均与海外MNC达成了重磅交易。国产创新药的研发进度和临床数据越来越在全球范围内占到优势，创新药BD出海受关税影响较小，有望继续通过授权出海的形式实现全球的商业化价值。报告中称，2025年4月10日，国家医保局正式宣告中国医疗保险研究会生育保险专业委员会成立。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282076.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","06978","BK1593","LU0417516571.SGD","LU2488822045.USD","BK0183","01530","LU1794554557.SGD","IE00BPRC5H50.USD","LU1720050803.USD","159992","00013","IE00B5MMRT66.SGD","IE00B543WZ88.USD","06990","LU0348783233.USD","BK0028","LU0196878994.USD","02162","09926","BK1587","BK1161","BK1574","LU0348784397.USD","002736","BK0188","BK1588","BK0276","BK1583"],"gpt_icon":0},{"id":"2529395970","title":"复宏汉霖盘中涨超9% 复星医药拟5.17亿港元增持复宏汉霖3.87%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2529395970","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529395970?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 10:42","pubTimestamp":1745289720,"startTime":"0","endTime":"0","summary":"　　复宏汉霖盘中涨超9%，截至发稿，股价上涨8.40%，现报36.80港元，成交额3593.75万港元。　　消息面上，复星医药公布，今年4月11日至17日期间，控股子公司复星医药产业与上海善梧、无锡通善、舟山果运及Henlink分别签订转让协议，控股子公司复星医药产业拟以24.60港元/股的价格受让上海善梧、无锡通善、舟山果运及Henlink合计持有的2103万股复宏汉霖非上市股份，转让价款共计5.17亿港元。在此次增持之后，复星医药持有复宏汉霖的股权比例将增至63.43%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-04-22/doc-inetzepa1054800.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","BK0183","BK0175","BK0028","BK0012","02696","BK0187","BK0239","BK0060","BK1161","BK1515","BK0096","BK0196","02196","BK0188","600196","BK1593"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":3,"totalSize":110,"code":"91000000","status":"200"}]}}